Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
40.93
+0.12 (0.29%)
At close: Apr 16, 2026, 4:00 PM EDT
40.88
-0.05 (-0.12%)
After-hours: Apr 16, 2026, 6:27 PM EDT
Novo Nordisk (NVO) Operating Income by Segment
History
| Date | Diabetes and Obesity Care | Rare Disease |
|---|---|---|
| Sep 30, 2025 | 20.69B | 191.24M |
| Jun 30, 2025 | 22.14B | 331.16M |
| Mar 31, 2025 | 21.21B | 84.36M |
| Dec 31, 2024 | 20.10B | 97.59M |
| Sep 30, 2024 | 18.53B | 104.04M |
| Jun 30, 2024 | 17.46B | 79.33M |
| Mar 31, 2024 | 16.79B | 430.48M |
| Dec 31, 2023 | 15.68B | 464.48M |
| Sep 30, 2023 | 14.26B | 365.00M |
| Jun 30, 2023 | 12.91B | 653.67M |
| Mar 31, 2023 | 11.83B | 864.11M |
| Dec 31, 2022 | 10.61B | 1.17B |
| Sep 30, 2022 | 9.80B | 1.43B |
| Jun 30, 2022 | 9.00B | 1.46B |
| Mar 31, 2022 | 8.41B | 1.47B |
| Dec 31, 2021 | 7.80B | 1.43B |
| Sep 30, 2021 | 7.36B | 1.48B |
| Jun 30, 2021 | 6.84B | 1.62B |
| Mar 31, 2021 | 6.73B | 1.58B |
| Dec 31, 2020 | 6.89B | 1.63B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.